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Abstract
All of the mouse models of human trisomy 21 syndrome that have been studied
so far are based on segmental trisomies, encompassing, to a varying extent, distal
chromosome 16. Their comparison with one or more unrelated and non-overlapping
segmental trisomies may help to distinguish the effects of speciﬁc triplicated genes
from the phenotypes caused by less speciﬁc developmental instability mechanisms. In
this paper, the Ts43H segmental trisomy of mouse chromosome 17 is presented as such
an alternative model. The trisomy stretches over 32.5 Mb of proximal chromosome
17 and includes 486 genes. The triplicated interval carries seven blocks of synteny
with ﬁve human chromosomes. The block syntenic to human chromosome 21 contains
20 genes. Copyright  2003 John Wiley & Sons, Ltd.
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Introduction
The presence of three copies of an autosome in the
mouse genome seriously impairs embryonic devel-
opment and almost invariably results in embryonic
lethality (Gropp et al., 1983; Hernandez and Fisher,
1999). In humans, one-half of all recognized spon-
taneous abortions are associated with aneuploidy,
half of these being due to a trisomy. Only three
human trisomies are compatible with partial post-
natal survival (but with extremely affected devel-
opment). The trisomy 21, known as Down’s syn-
drome (DS), is the most frequent cause of mental
retardation with an incidence of 1 per 700 new-
borns. Only 10% of foetuses with trisomy 21 sur-
vive to term (Epstein, 1988). Trisomies 18 and 13,
causing Edwards and Patau syndromes, are also
semi-viable but display even more severe clinical
features (Nicolaidis and Petersen, 1998).
Two hypotheses, which are not mutually exclu-
sive, were proposed to explain why an extra copy
of an otherwise normal autosome has such dev-
astating effects on development. According to the
‘dosage-sensitive genes’ hypothesis, the trisomic
region carries a subset of genes, which when trip-
licated are responsible for all pathological features
(Korenberg et al., 1994). An extra copy of a par-
ticular dosage-sensitive gene is assumed to account
for a particular phenotypic trait in a trisomic organ-
ism. According to the ‘developmental instability’
hypothesis, the massive overexpression of tripli-
cated genes results in a non-speciﬁc breakdown
of the gene regulatory networks during develop-
ment and consequently in chaos of ﬁne tuning of
developmental pathways (Pritchard and Kola 1999;
Shapiro 1997). This hypothesis questions attempts
to link particular triplicated genes to particular
traits. Instead, it predicts that an extra copy of any
autosomal segment of sufﬁcient length, with a suf-
ﬁcient number of expressed genes, is likely to cause
a developmental breakdown.
Because of its high incidence and clinical impor-
tance, almost all papers on the molecular nature
of human trisomies have been focused on DS, at
the identiﬁcation of critical chromosomal regions
or on attempts to positionally clone candidate genes
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for particular pathological traits. Admittedly, in
spite of extensive experimental efforts, not a sin-
gle candidate gene, when used as a transgene in
the mouse model, has fully recapitulated the rele-
vant trait. However, when using the extra copy of a
chromosomal segment in the mouse segmental tri-
somy models, it was possible to recapitulate several
major traits including cognitive defects, character-
istic skull dysgenesis or cerebellar maldevelopment
(Reeves et al., 2001).
To evaluate which phenotypic feature or gene
expression anomaly can be attributed to the devel-
opmental instability hypothesis and which is com-
patible with the idea of dosage-sensitive genes, it
may be helpful to use different mouse trisomic
models that replicate human trisomy 21. By search-
ing for features that are common to two unrelated
and non-overlapping mouse trisomies, the speci-
ﬁcity of the observed phenotypes can be evaluated.
Here we introduce the Ts43H segmental trisomy
that triplicates the proximal part of the mouse chro-
mosome 17, from the centromere to the H2-K
gene, which could be used for such a purpose.
Because 20 out of 486 triplicated genes within the
Ts43H trisomic interval are orthologous to genes
on human chromosome 21, we start with a brief
description of syntenies between human chromo-
some 21 and the mouse genome and with a com-
parison of Ts43H to other viable mouse segmental
trisomies.
Regions of synteny between human
chromosome 21 and the mouse genome
The total length of human chromosome 21 is
46.98 Mb, representing 1.5% of the human genome
and carrying 1.1% (273/24261) of all human
genes (according to the Human Genome Browser,
Release 16.33.1: http://www.ensembl.org/
Homo sapiens/). Following the concept of the
dosage-sensitive gene hypothesis, the ideal mouse
model of human DS would carry three copies of
all of the mouse genes with orthologues on human
chromosome 21. However, during 75 million years
of separate evolution, the human and mouse
genomes have been reshufﬂed by chromosomal
rearrangements so that, at present, the regions
of synteny with human chromosome 21 can be
found on three mouse chromosomes (27.9 Mb on
chromosome 16, 2.9 Mb on chromosome 10 and
1.6 Mb on chromosome 17: Figure 1; Table 1).
The syntenic region on mouse chromosome 16
has been studied thoroughly using the segmental
trisomies Ts65Dn, Ts1Cje and their derivatives
(Dierssen et al., 2001; Kola and Hertzog, 1998;
Reeves et al., 2001). A viable mouse trisomy of
the A1–C1 bands of chromosome 10 originated
from the T(10;13)199H translocation (Eicher and
Washburn, 1977; Lyon and Meredith, 1966). The
available mapping data of the T199H breakpoint
on chromosome 10 (Beechey and Evans, 1996)
suggest that the Ts199H trisomic region most likely
encompasses the block of genes syntenic with
human chromosome 21. The interval on mouse
chromosome 17 syntenic to human chromosome
21 is triplicated in the Ts43H segmental trisomy,
which is a derivative the of T(16;17)43H reciprocal
translocation.
Origin and characteristics of the
T(16;17)43H translocation and the
Ts43H trisomy
The reciprocal translocation between chromosomes
16 and 17, T(16;17)43H, was generated by the irra-
diation of sperm cells of a (C3H × 101)F1 hybrid
Table 1. Length and gene content of mouse chromosomal regions (chromosomes 10, 16 and 17) syntenic to human
chromosome 21∗
Mouse synteny
to human
chromosome 21
Human
Ensembl
map (Mbp)
Length of
human
synteny (Mbp)
Number of
human genes
Mouse
Ensembl
map (Mbp)
Length of
mouse
synteny (Mbp)
Number of
mouse genes
Chromosome 10 44.0–46.9 2.9 59 76.0–78.3 2.3 47
Chromosome 16 14.4–42.3 27.9 151 76.0–98.6 22.6 172
Chromosome 17 42.4–44.0 1.6 25 29.7–30.8 1.1 20
Total 32.4 235 26 239
∗ Based on Mouse Genome Assembly NCBI 30 (http://www.ensembl.org/Mus musculus/).
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Figure 1. Regions of synteny between human chromosome
21 and the mouse genome. The intervals of mouse
chromosome 16 triplicated in segmental trisomies Ts65Dn,
Ts1Cje and MsTs65Dn are indicated. The trisomies T43H
and Ts199H have not been used so far for analysis of genes
corresponding to human chromosome 21
male (Searle et al., 1974). The translocation causes
the complete arrest of spermatogenesis in males,
but T43H/+ female heterozygotes are fertile. Male
fertility can be restored by combining the T43H
and Rb(16;17)Bnr translocations. Using this ploy
it was possible to generate T43H/T43H homozy-
gous stock, which proved to be fertile in both sexes
(Gregorova et al., 1981).
Viable Ts43H mice with segmental trisomy of
the proximal part of chromosome 17 arise as a
product of adjacent II disjunction in female meiosis
of T43H translocation heterozygotes (Forejt, 2002;
Forejt et al., 1980). The frequency of viable tri-
somics in the progeny varies, depending on the
genetic background, from 0% to 20%, and can be
enhanced by the presence of a t-haplotype (Cap-
kova et al. 1986; Gregorova et al., 1981). The
Ts43H trisomic mice have 40 chromosomes but,
in contrast to euploid wild-type mice, one chro-
mosome 16 carries an extra copy of the prox-
imal region of chromosome 17 on the top of
its centromeric heterochromatin (Figure 2). The
Ts43H trisomics can be identiﬁed by cytogenetic
methods, detecting a unique interstitial C-band on
the 1716 marker chromosome and the simultaneous
absence of the small 1617 translocation product. A
single nucleotide primer extension method (SnuPE)
was developed for DNA genotyping the Ts43H tri-
somics (Vacik and Forejt, 2003) and more recently
a diagnostic microsatellite marker was found with
three different alleles in the three chromosomes
engaged in the segmental trisomy (Vacik, unpub-
lished results). The translocation breakpoint on
chromosome 17 was shown to be tightly linked, but
proximal, to the H2K gene (Forejt et al., 1980).
Regions of synteny between the Ts43H
segmental trisomy and the human
genome
The Ts43H triplicated region stretches from the
centromere of chromosome 17 to the T43H translo-
cation break. It is 32.5 Mb long and carries 486
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Figure 2. The chromosomes involved in the Ts43H
trisomy and the corresponding human syntenic regions.
The triplicated part of chromosome 17 is framed
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genes, representing 1.3% of mouse genome and
1.9% of mouse genes. This region of chromosome
17 overlaps with the T–t-haplotype complex, the
naturally occurring variant form of chromosome
17 composed of four adjacent inversions and a
series of lethal mutations (Hammer et al., 1989;
Lyon, 2000). The unstable character of the region
is also obvious when it is compared with the human
genome. The Ts43H interval shows seven blocks of
synteny with ﬁve human chromosomes (Figure 2;
Table 2). The block syntenic to human chromo-
some 21 carries 20 genes (Table 3) and their
expression analysis can be used to complete the
set of existing mouse DS models. The triplicated
region includes 16 genes with orthologues in the
list of human disease genes (Table 4) in the Online
Mendelian Inheritance in Man (OMIM) database
(http://www.ncbi.nlm.nih.gov/Omim/).
The imprinted genes within the
triplicated region
Mouse chromosome 17 carries four imprinted
genes, insulin-like growth factor 2 receptor (Igf2r),
Table 2. Length and gene content of regions of synteny between the Ts43H trisomic interval of mouse chromosome17
and human chromosomes 5, 6, 16, 19 and 21∗
Human
synteny
to Ts43H
Mouse
Ensembl
map (Mbp)
Length
of mouse
synteny (Mbp)
Number
of mouse
genes
Human
Ensembl
map (Mbp)
Length
of human
synteny (Mbp)
Number
of human
genes
Chromosome 6 3.0–13.9 10.9 108 150.3–170.3 20.0 113
Chromosome 5 14.2–16.2 2.0 14 96.2–98.4 2.2 12
Chromosome 16 22.2–25.0 2.8 145 0.2–3.2 3.0 136
Chromosome 5 25.0–25.6 0.6 10 171.9–172.6 0.7 10
Chromosome 6 25.6–29.7 4.1 79 33.4–39.1 5.7 75
Chromosome 21 29.7–30.8 1.1 20 42.4–44.0 1.6 25
Chromosome 19 30.8–31.3 0.5 8 15.1–15.6 0.5 12
Total 22.0 384 33.7 383
∗ Based on Mouse Genome Assembly NCBI 30 (http://www.ensembl.org/Mus musculus/).
Table 3. Map coordinates of mouse genes from the Ts43H trisomic region with orthologues on human chromosome21
Ensembl gene ID Gene symbol
Mouse Ensembl
map (Mb)
Mouse MGI
map (cM)
Human Ensembl
map (Mb)
ENSMUSG00000024030 Abcg1 29.77 — 42.53
ENSMUSG00000024029 Tff3 29.84 17.0 42.63
ENSMUSG00000024028 Tff2 29.86 17.0 42.66
ENSMUSG00000024032 Tff1 29.88 17.0 42.68
ENSMUSG00000024034 Tmprss3 29.90 — 42.69
ENSMUSG00000042345 (UBASH3A) 29.92 — 42.72
ENSMUSG00000024033 Tsga2 29.97 13.25 42.79
ENSMUSG00000024036 (SLC37A1) 30.00 — 42.83
ENSMUSG00000041119 Pde9a 30.10 — 42.97
ENSMUSG00000024037 Wdr4 30.21 — 43.16
ENSMUSG00000024038 1500032D16Rik 30.23 — 43.20
ENSMUSG00000013562 4833413E03Rik 30.27 — —
ENSMUSG00000006705 Pknox1 30.29 — 43.29
ENSMUSG00000024039 Cbs 30.32 17.4 43.37
ENSMUSG00000046684 — 30.35 — —
ENSMUSG00000024040 U2af1 30.36 — 43.41
ENSMUSG00000024041 Cryaa 30.39 17.4 43.48
ENSMUSG00000024042 Snf1lk 30.55 18.18 43.69
ENSMUSG00000002076 Hsf2bp 30.65 — 43.81
ENSMUSG00000002070 2600005C20Rik 30.75 — 43.94
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Table 4. List of human disease genes (OMIM) with mouse
orthologues in the Ts43H trisomic region
Chromo-
some No.
Gene
symbol
Disease
OMIM ID Disease description
5 NKX2-5 600584 Atrial septal defect with
atrioventricular conduction
defects
6 ACAT2 100678 ACAT2 deﬁciency
6 IGF2R 147280 Hepatocellular carcinoma
6 LPA 152200 Coronary artery disease,
susceptibility to
6 PLG 173350 Plasminogen Tochigi’s
disease
6 PARK2 602544 Parkinson’s disease, juvenile,
type 2
6 HMGA1 600701 Lipoma
6 TULP1 602280 Retinitis pigmentosa
6 MTCH1 176801 Gaucher’s disease, variant
form
16 HAGH 138760 Glyoxalase II deﬁciency
16 TSC2 191092 Tuberous sclerosis-2
16 PKD1 601313 Polycystic kidney disease,
adult type I
19 NOTCH3 600276 Cerebral arteriopathy with
subcortical infarcts and
leukoencephalopathy
21 TMPRSS3 601072 Deafness, autosomal
recessive
21 CBS 236200 Homocystinuria,
B6-responsive and
non-responsive types
21 CRYAA 123580 Cataract, congenital,
autosomal dominant
insulin-like growth factor 2 receptor antisense
RNA (Air) and solute carrier family 22 mem-
bers 2 and 3 (Slc22a2 and Slc22a3). All of
them are in one imprinted domain within the
Ts43H region and all but Air are paternally
repressed. Recently, a large-scale expression pro-
ﬁling of 9.5 dpc parthenogenote and androgenote
mouse embryos revealed 34 transcripts within the
Ts43H region that are either imprinted or regulated
by imprinted genes (Nikaido et al., 2003). The
monoallelic expression of imprinted genes can be
viewed as a special case of gene-dosage regulation
(Vacik and Forejt, 2003), which makes them poten-
tial candidates for dosage-sensitive genes within
the trisomic regions. The analysis of expression of
the Igf2r gene in Ts43H trisomics showed that the
paternal repression and maternal transcription of
Igf2r was not affected in trisomics, regardless of
whether the extra copy was of paternal or maternal
origin. Moreover, mRNA levels of the Igf2r gene
did not differ in mouse embryos with one or two
active copies of the gene, indicating some kind of
dosage compensation mechanism controlling this
triplicated imprinted gene (Vacik and Forejt, 2003).
Future prospects of the Ts43H trisomy
as a model of aneuploidy syndromes
Recent expression proﬁling experiments have
revealed global upregulation of chromosome 21
gene expression in foetal DS brains (Mao et al.,
2003) and general misregulation of genes outside
the trisomy in cultured human foetal cells
(FitzPatrick et al., 2002) as well as in the cerebellar
transcriptome of adult Ts65Dn trisomic mice
(Saran et al., 2003). These data strongly suggest,
but do not prove, that the global destabilization
of gene regulation plays an important role in the
phenotypic manifestation of such aneuploidies.
The Ts43H trisomy can be used for experimental
testing of both hypotheses, by searching for dosage-
sensitive genes and by comparing it with unrelated
trisomies, such as Ts65Dn or Ts199H. Analysis of
Ts43H mice has just begun and the ﬁrst results on
learning deﬁcit and expression proﬁling in brains
are encouraging (Vacik, Orth, Gregorova, Strnad,
Bures and Forejt, manuscript in preparation). Com-
parisons between two or more viable segmental
trisomies may bring new answers to some of the
old questions provoked by the two previously men-
tioned hypotheses, including:
• Are there any phenotypic features or gene
expression patterns common to unrelated seg-
mental trisomies that are not observed in wild-
type siblings? To assess the phenotypes prop-
erly, the complex examination of trisomics and
their wild-type littermates should be done fol-
lowing established programs, such as those of
Mouse Phenome project (Paigen and Eppig,
2000) (http://aretha.jax.org/pub-cgi/phenome/
mpdcgi?rtn=docs/home) or the ‘Mouse Clinic’
(http://www.gsf.de/ieg/gmc/index.html).
• Why do a fraction of segmental trisomics die
before term? Is there any genetic or epigenetic
difference between the prospectively viable and
prospectively lethal trisomic foetuses? If there
is such a difference, is it shared by unrelated
trisomies? What is the nature of the abnormal
phenotypic variability observed in segmental
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aneuploidies? Can we ﬁnd modiﬁer genes that
would suppress some of the pathological features
associated with segmental aneuploidies?
• Is it the size of the triplicated segment, or its
speciﬁc gene content, that determines particu-
lar pathological features? A combination of the
Ts43H trisomy with various deletions created
in the same chromosomal interval in Dr Schi-
menti’s laboratory (Chao et al., 2003) could be
instrumental in this respect.
These are some of the problems that can be
studied by comparing unrelated mouse models of
segmental trisomies, utilizing all of the advantages
provided by current mouse genetic and genomic
methodologies.
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